FindTrial
Sign In

A study to understand the applicability of OPtimal Treatment of Angina (OPTA) questionnaire in patients with stable ischemic heart disease

A study to understand the applicability of OPtimal Treatment of Angina (OPTA) questionnaire in patients with stable ischemic heart disease in routine/real world clinical practice in India.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/035263
Enrollment
500
Registered
2021-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20-I25- Ischemic heart diseases

Interventions

None listed

Sponsors

Abbott Healthcare Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male and female patients >18 years of age 2. Patients who have completed at least 10 years of school education 3. Patients with a confirmed history of stable ischemic heart disease documented in their medical records and who are on medical therapy for at least the past 3 months.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of coronary artery bypass grafting within the past 6 months 2. Patients with a history of ACS and/or percutaneous transluminal coronary angioplasty (PTCA) within the past 6 months 3. Any patient found to be unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
To understand the applicability of OPtimal Treatment of Angina (OPTA) questionnaire in patients with stable ischemic heart disease in routine/real world clinical practice in India.Timepoint: Day-1—

Secondary

MeasureTime frame
To understand the applicability of OPtimal Treatment of Angina (OPTA) questionnaire in patients with stable ischemic heartTimepoint: Day-1—

Countries

India

Contacts

Public ContactDr Shivani Acharya

Abbott Healthcare Private Limited

jejoe.karankumar@abbott.com7045011810

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026